$BHC 3 SEC Filings

Filed On	Filing
20 May 2026	Form 3: Roberts Eiry, Director No securities owned
14 Aug 2025	Form 3: Paulson & Co. Inc., 10% owner Holds 70,755,869 shares of Common Stock, without par value
29 Jul 2025	Form 3: Goettler Michael, Director No securities owned
29 Jul 2025	Form 3: Leung Sandra, Director No securities owned
15 Jul 2025	Form 3: Lee Steven Hyosig, SVP, Controller & CAO No securities owned
20 Aug 2024	Form 3: Charhon Jean-Jacques, EVP, CFO No securities owned
17 Jul 2024	Form 3: Lenar Aimee J., EVP, US Pharma No securities owned
21 May 2024	Form 3: Lee Frank D., Director No securities owned
20 May 2024	Form 3: Garcia Christian A, Director No securities owned
21 Jun 2022	Form 3: Barresi John S, SVP, Controller & CAO No securities owned
12 May 2022	Form 3: Carson Seana, EVP, General Counsel Holds 68,570 shares of Common Shares, No Par Value
12 May 2022	Form 3: Vadaketh Tom George, EVP, Chief Financial Officer Holds 101,623 shares of Common Shares, No Par Value
12 May 2022	Form 3: Mulligan Richard, Director No securities owned
05 May 2022	Form 3: Bausch Health Companies Inc., 10% owner · Bausch + Lomb Corp Holds 350,000,000 shares of Common Shares, No Par Value
03 Jun 2021	Form 3: Munsch Frederick, SVP, Controller and CAO Holds 21,172 shares of Common Shares, No Par Value
24 Mar 2021	Form 3: Miller Steven D, Director Holds 100 shares of Common Shares, No Par Value
24 Mar 2021	Form 3: Icahn Brett, Director No securities owned
01 Jun 2020	Form 3: Spurr Robert, President, Salix Holds 40,250 shares of Common Shares, No Par Value
31 Oct 2018	Form 3: Von Eschenbach Andrew C., Director Holds 1,000 shares of Common Shares, No Par Value
10 Aug 2018	Form 3: McKenna Mark C., President, Salix Holds 21,131 shares of Common Shares, No Par Value

Comments